Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
This grant opportunity aims to support the validation of biomarkers—such as individual biomarkers, composites, or signatures—through analytical or clinical methods. The validation process should be rigorous and align with guidelines from the FDA's Biomarker Qualification Program or other FDA regulatory pathways.
Alzheimer’s disease (AD) and AD-related dementias (ADRD) are complex brain disorders that affect millions of Americans and are among the greatest healthcare challenges of the 21 st century. NIA , as the primary federal agency for AD research, supports research spanning from basic understanding o…
Funding Source
Eligibility
- Foreign components are allowed as defined in the NIH Grants Policy Statement.
- Required registrations (must be completed before submission; registration can take 6+ weeks and failure to register is not a valid reason for late submission): • System for Award Management (SAM) – Activ…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers